| | Cancer | Cancer Treatment
Duodenal Cancer Prevention: Risk Reduction and Early Detection
No Guaranteed Prevention, But Risk Reduction Is Possible
Duodenal adenocarcinoma is rare (<1% of GI cancers). Risk factors are modifiable and non-modifiable.
Modifiable Risk Factors
- Diet: High red/processed meat, low fiber/fruit/veg → ↑ risk. Mediterranean pattern protective.
- Obesity: BMI ≥30 → chronic inflammation, insulin resistance.
- Smoking: Dose-dependent risk increase.
- Alcohol: Heavy use → ↑ risk.
- H. pylori: Eradication may reduce duodenal cancer (evidence stronger for gastric).
- Occupational exposures: Certain chemicals (limited evidence).
Non-Modifiable / Medical Risk Factors
- Familial adenomatous polyposis (FAP) → near 100% duodenal adenomas; surveillance mandatory.
- Lynch syndrome (MSH2/MLH1).
- Peutz-Jeghers syndrome.
- Celiac disease (↑ lymphoma, adenocarcinoma risk).
- Crohn's disease (small bowel involvement).
- Prior radiation.
Surveillance for High-Risk Groups
- FAP: Upper endoscopy (side-viewing duodenoscope) every 1–3 years starting age 20–25.
- Lynch/PJS: Per syndrome guidelines.
- Celiac: Consider endoscopy if refractory symptoms.
Symptoms Warranting Urgent Evaluation
- Epigastric pain, weight loss, anemia, nausea/vomiting, melena, jaundice (ampullary).
Cancer Treatment - Related Articles
- Clodronate: Understanding Side Effects & Uses in Cancer Treatment
- Anti-Angiogenesis Drugs: Side Effects & Immune System Impacts
- A History of Cancer Therapy: From Ancient Practices to Modern Treatments
- Local vs. Systemic Cancer Therapy: Key Differences
- Vitamins & Cancer: Boosting Immunity & Treatment Effectiveness
- Cancer Treatment Advances: Precision Medicine, Immunotherapy, and Future Directions
- Proton Therapy: A Modern Approach to Cancer Treatment
